HOOKIPA Pharma Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
HOOK on Nasdaq
Industry
Pharmaceutical Preparations
Location
350 Fifth Avenue, 72 Nd Floor, Suite 7240, New York, NY

Insiders trading volume in the past year

HOOKIPA Pharma Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Gilead Sciences, Inc. 10%+ Owner $13.6M Dec 20, 2023
Jorn Aldag Chief Executive Officer, Director $2.97M Apr 15, 2024
Reinhard Kandera Chief Financial Officer, Director $1.25M Apr 15, 2024
Roman Necina Chief Operations Officer $1.1M Apr 15, 2024
Klaus Orlinger Chief Scientific Officer $1.1M Apr 15, 2024
Christine D. Baker Chief Operating Officer $827K Apr 14, 2023
Katia Schlienger Chief Medical Officer $553K Apr 14, 2023
Igor Matushansky Chief Medical Officer $352K Jun 30, 2022
Jan van de Winkel Director $156K Jun 17, 2024
Mark Winderlich Chief Development Officer $150K Apr 15, 2024
David Ross Kaufman Director $78K Jun 17, 2024
Timothy P. Reilly Director $78K Jun 17, 2024
Julie O'Neill Director $78K Jun 17, 2024
Michael Aaron Kelly Director $60K Jun 30, 2022
Mary Theresa Coelho EVP and CFO, Director $51.8K -$12.5K -19.5% Jul 22, 2025
Malte Peters Chief Executive Officer, Director $44.7K -$47.5K -51.6% Aug 19, 2025
Graziano Seghezzi Director $28.8K Jun 1, 2021
Christoph Lengauer Director $28.8K Jun 1, 2021
Jean-Charles Soria Director $28.8K Jun 1, 2021
Sean A. Cassidy Director Jul 22, 2024

Recent Insider Transactions by Companies or Individuals for HOOKIPA Pharma Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.